Is TNFA or NOBL a better dividend investment in 2026?

TNFA currently yields 38.46% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: TNFA offers higher current income.

What is the dividend yield difference between TNFA and NOBL?

TNFA has a forward dividend yield of 38.46% ($2.00/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 36.29 percentage points.

Home › Compare › TNFA vs NOBL

TNFA vs NOBL: Dividend Comparison 2026

TNFA yields 38.46% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TNFA wins by $190.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

TNFA

● Live price

38.46%

Share price

$5.20

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$213.1K

Annual income

$34,859.06

Full TNFA calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — TNFA vs NOBL

📍 TNFA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TNFA	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TNFA + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TNFA pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TNFA

Annual income on $10K today (after 15% tax)

$3,269.23/yr

After 10yr DRIP, annual income (after tax)

$29,630.20/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, TNFA beats the other by $29,417.89/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TNFA + NOBL for your $10,000?

TNFA: 50%NOBL: 50%

100% NOBL50/50100% TNFA

Portfolio after 10yr

$118.0K

Annual income

$17,554.42/yr

Blended yield

14.87%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TNFA buys

NOBL buys

No recent congressional trades found for TNFA or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTNFANOBL

Forward yield	38.46% ✓	2.17%
Annual dividend / share	$2.00	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$213.1K ✓	$22.9K
Annual income after 10y	$34,859.06 ✓	$249.78
Total dividends collected	$158.5K ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: TNFA vs NOBL ($10,000, DRIP)

Year	TNFA Portfolio	TNFA Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$14,546	$3,846.15	$10,917	$217.08	+$3.6K → TNFA
2	$20,793	$5,228.67	$11,903	$221.48	+$8.9K → TNFA
3	$29,234	$6,985.18	$12,962	$225.68	+$16.3K → TNFA
4	$40,458	$9,178.25	$14,099	$229.68	+$26.4K → TNFA
5	$55,162	$11,871.34	$15,319	$233.49	+$39.8K → TNFA
6	$74,150	$15,126.76	$16,628	$237.10	+$57.5K → TNFA
7	$98,344	$19,003.53	$18,033	$240.53	+$80.3K → TNFA
8	$128,783	$23,555.24	$19,539	$243.78	+$109.2K → TNFA
9	$166,626	$28,828.07	$21,154	$246.86	+$145.5K → TNFA
10	$213,149	$34,859.06	$22,884	$249.78	+$190.3K → TNFA

TNFA vs NOBL: Complete Analysis 2026

TNFA — Stock

TNF Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Full TNFA Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this TNFA vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TNFA vs SCHD TNFA vs JEPI TNFA vs O TNFA vs KO TNFA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.